Page last updated: 2024-08-16

technetium tc 99m sestamibi and Sclerosis, Systemic

technetium tc 99m sestamibi has been researched along with Sclerosis, Systemic in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YW; Ding, HJ; Ho, ST; Kao, A; Lin, CC; Wang, JJ1
Belloli, L; Carlo-Stella, N; Chiti, A; Ciocia, G; Marasini, B; Massarotti, M1
Park, CH; Richard, MD1
Cox, D; Earle, L; Richard, M; Varga, J1
Banci, M; Barbieri, C; Boccabella, GL; DeSantis, M; Ierardi, M; Morelli, S; Rinaldi, E; Scopinaro, F; Tiberio, NS1
Higuchi, T; Kawano, M; Nakajima, K; Nishijima, C; Sato, S; Takehara, K; Taki, J; Tonami, N1

Trials

1 trial(s) available for technetium tc 99m sestamibi and Sclerosis, Systemic

ArticleYear
Usefulness of technetium-99m sestamibi myocardial perfusion SPECT in detection of cardiovascular involvement in patients with systemic lupus erythematosus or systemic sclerosis.
    International journal of cardiology, 2003, Volume: 92, Issue:2-3

    Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Electrocardiography; Female; Heart; Humans; Lupus Erythematosus, Systemic; Radiopharmaceuticals; Risk Factors; Scleroderma, Systemic; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

2003

Other Studies

5 other study(ies) available for technetium tc 99m sestamibi and Sclerosis, Systemic

ArticleYear
Myocardial involvement in systemic sclerosis.
    Rheumatology (Oxford, England), 2008, Volume: 47, Issue:7

    Topics: Adult; Aged; Cardiomyopathies; Female; Humans; Male; Middle Aged; Radiopharmaceuticals; Risk Factors; Scleroderma, Systemic; Severity of Illness Index; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

2008
Tc-99m MIBI uptake secondary to pulmonary interstitial fibrosis in progressive systemic sclerosis.
    Clinical nuclear medicine, 1995, Volume: 20, Issue:3

    Topics: Female; Heart; Humans; Lung; Middle Aged; Pulmonary Fibrosis; Scleroderma, Systemic; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

1995
Abnormal uptake of Tc-99m MIBI, a novel myocardial imaging agent, in the lungs of patients with systemic sclerosis.
    Clinical nuclear medicine, 1998, Volume: 23, Issue:1

    Topics: Coronary Disease; Dyspnea; Endothelium, Vascular; Female; Fibroblasts; Heart; Humans; Injections, Intravenous; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Mitochondria; Pilot Projects; Pulmonary Diffusing Capacity; Pulmonary Fibrosis; Radionuclide Imaging; Radiopharmaceuticals; Scleroderma, Systemic; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Total Lung Capacity; Vital Capacity

1998
99mTc SESTAMIBI scintigraphic evaluation of skeletal muscle disease in patients with systemic sclerosis: diagnostic reliability and comparison with cardiac function and perfusion.
    Angiology, 1998, Volume: 49, Issue:8

    Topics: Cardiomyopathies; Case-Control Studies; Female; Heart; Humans; Male; Middle Aged; Muscle, Skeletal; Muscular Diseases; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Scleroderma, Systemic; Technetium Tc 99m Pentetate; Technetium Tc 99m Sestamibi

1998
Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: an early sign of cardiac involvement.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:2

    Topics: Coronary Circulation; Diastole; Female; Heart Diseases; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Radiopharmaceuticals; Scleroderma, Systemic; Stroke Volume; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left

2001